Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Autologous Platelets Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified medical advice, visits or professional assistance with a genuine dr.. We are not doctors. Always consult your mD about Autologous Platelets conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Autologous Platelets Clinical research trials and Autologous Platelets medical trials take place in many of places throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new does drugs. The purpose of the studies / projects is to solve specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to find cures for all varieties of conditions, like Autologous Platelets. Autologous Platelets Clinical Trials and other clinical trials allow for volunteers to have health treatment options before they are available to the masses. Many times the human subjects acquire professional assistance for free of charge, and sometimes they are compensated for their time. Occasionally there is a cost for a Autologous Platelets clinical trial. Test subjects typically obtain the finest healthcare available for their Autologous Platelets condition. Dangers are a reality, nevertheless, and might include additional or frequent doctor trips, medical dangers (possibly life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.

Home > "A" Clinical Trials Conditions > Autologous Platelets

Autologous Platelets



Autologous Platelets

For Condition: Leukemia,Lymphoma
Status: Recruiting
Sponsor(s): M.D. Anderson Cancer Center ,
Synopsis: The objectives of this study are to determine the corrected count increment (CCI) of autologous transfused platelets that had been stored by cryopreservation with Thrombosol compared to fresh random platelets and to determine the safety of transfusing autologous platelets cryopreserved with Thrombosol.
Details: The current method for cryopreservation of platelets is unsatisfactory due to the use of high concentration of cryoprotectants and poor numerical and functional recovery of platelets following the thawing of the cells. The use of Thrombosol for the cryopreservation of platelets yields high retention of in vitro and in vivo numerical and functional activity in conjuction with a directly transfusable formulation. This platelet preservation system will allow for the effective long-term storage of autologous platelets.
Eligibility:
Study Type:
  Interventional, Treatment, Randomized
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: - Patients in remission with ALL, CLL, AML, CML, MDS will be allowed to participate if their platelet count is > 150K and the hemoglobin level is at least 8.0 g/dl. - Patients with detectable malignant cells or ongoing marrow involvement by the tumor will not be elgible.
Total Enrollment: 54

Location and Contact Information:

UT M.D. Anderson Cancer Center *Recruiting*
Houston,  Texas,  77030
United States
Recruiting Benjamin  Lichtiger 713-792-6313


Additional Information:
Study ID Numbers:
  ID03-0088; 
Study Start Date: November 2003
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00074763

Other Leukemia Studies:
1. Donor Stem Cell Transplantation in Treating Patients With Relapsed Hematologic Cancer

2. A Phase I Study of Infusional Chemotherapy with the P-Glycoprotein Antagonist PSC 833

3. T-Cell-Depleted Allogeneic Stem Cell Transplantation Followed By Treated Donor T Cells After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies

4. Stem Cell Transplantation in Treating Patients with Hematologic Cancer

5. The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells from Normal Volunteers and Volunteers with Lymphoid or Hematologic Malignancies

Related Studies:

Other Leukemia Clinical Trials
Other Texas Clinical Trials
Other Houston Clinical Trials

Autologous Platelets

Modify your Search

  Other Leukemia Clinical Trials
  Other Texas Clinical Trials
  Other Houston Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103